Author(s): Anagha S. Patil


DOI: 10.5958/2231-5713.2016.00039.8   

Address: Anagha S. Patil
Lecturer, SATS Diploma in Pharmacy College, Miraj 416414
*Corresponding Author

Published In:   Volume - 6,      Issue - 4,     Year - 2016

Counterfeit drugs are market from a big portion of India’s domestic drug market. Indian government point out that 0.4 percent of countries drugs is counterfeit. World Health Organisation estimated that the counterfeit drugs make up about 25 percent in developed countries. Experts says the global fake drug industry worth about $ 90 billion causes the death of almost 1 million people a year and is contributing a rise in drug resistance. Counterfeit products have no therapeutic effect, at worst the patient can die from it and these are prove to be dangerous to public health because they are not produced under safe manufacturing procedure and also they are not inspected by regulatory authorities. Local drug maker says such allegation of counterfeit drugs is attempts by international drug makers to scuttle competition from generic companies. India become a hub for the fake medicines, to overcome this government of India has made it mandatory for drug makers to carry a barcode on every product exported out of country to put an end to allegations overseas that some local firms ship out counterfeit medicines. Pharmacist has wild range of responsibilities regarding the counterfeit drugs. Consumers also judge whether the medications are counterfeit or not by providing the information.

Cite this article:
Anagha S. Patil.Counterfeit Drugs: A Review. Asian J. Pharm. Tech. 2016; 6(4): 273-276. doi: 10.5958/2231-5713.2016.00039.8

Recomonded Articles:

Author(s): Anagha S. Patil

DOI: 10.5958/2231-5713.2016.00039.8         Access: Open Access Read More

Asian Journal of Pharmacy and Technology (AJPTech.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5713 

Recent Articles